T Hashimoto Selected Research

T Hashimoto Research Topics

Disease

68	Pemphigus (Pemphigus Vulgaris) 01/2020 - 01/2000
45	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2000
32	Neoplasms (Cancer) 01/2019 - 01/2000
14	Skin Diseases (Skin Disease) 03/2022 - 05/2000
12	Blister (Bulla) 12/2017 - 01/2000
11	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 04/2019 - 11/2001
10	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 01/2017 - 07/2000
8	Carcinoma (Carcinomatosis) 06/2008 - 01/2000
7	Infections 11/2008 - 04/2000
6	Linear IgA Bullous Dermatosis 11/2016 - 12/2000
6	Schizophrenia (Dementia Praecox) 02/2008 - 05/2000
5	Inflammation (Inflammations) 01/2019 - 02/2000
5	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 03/2014 - 01/2000
5	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2013 - 06/2000
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2003 - 07/2000
4	Acantholysis 01/2019 - 01/2000
4	Cicatrix (Scar) 12/2017 - 02/2000
4	Alzheimer Disease (Alzheimer's Disease) 04/2014 - 11/2000
4	Autistic Disorder (Autism) 07/2011 - 09/2000
4	Insulin Resistance 02/2006 - 01/2000
4	Adenocarcinoma 08/2001 - 02/2000
4	Seizures (Absence Seizure) 07/2001 - 05/2000
4	Heart Failure 07/2001 - 04/2000
3	Disease Progression 10/2016 - 05/2001
3	Bronchiolitis Obliterans 12/2015 - 02/2000
3	Hypersensitivity (Allergy) 11/2015 - 04/2000
3	Thymoma (Thymic Carcinoma) 07/2015 - 08/2000
3	Atherosclerosis 01/2014 - 01/2000
3	Respiratory Insufficiency (Respiratory Failure) 06/2013 - 02/2000
3	Hemorrhage 04/2010 - 09/2004
3	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 05/2009 - 11/2000
3	Necrosis 04/2004 - 07/2000
3	Lung Neoplasms (Lung Cancer) 03/2003 - 02/2000
3	Hypertension (High Blood Pressure) 02/2002 - 09/2000
3	Chronic Pancreatitis 12/2001 - 10/2000
3	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 11/2001 - 10/2000
3	Myocardial Infarction 11/2001 - 03/2000
2	Atopic Dermatitis (Atopic Eczema) 11/2022 - 05/2003
2	Ischemic Stroke 01/2022 - 08/2000
2	Castleman Disease (Castleman's Disease) 01/2017 - 04/2016
2	Alcoholism (Alcohol Abuse) 01/2016 - 09/2015
2	Pneumonia (Pneumonitis) 01/2016 - 10/2007
2	Sclerosing Cholangitis 11/2015 - 06/2001

Drug/Important Bio-Agent (IBA)

54	AutoantibodiesIBA 01/2020 - 01/2000
42	Immunoglobulin G (IgG)IBA 04/2019 - 01/2000
36	AntibodiesIBA 01/2020 - 01/2000
33	Immunoglobulin A (IgA)IBA 01/2017 - 01/2000
18	Proteins (Proteins, Gene)FDA Link 04/2019 - 01/2000
18	AntigensIBA 06/2013 - 01/2000
17	DesmocollinsIBA 07/2016 - 11/2000
15	EnzymesIBA 12/2017 - 05/2000
14	ImmunosorbentsIBA 12/2017 - 05/2000
12	Desmoglein 1IBA 07/2015 - 01/2000
11	DesmogleinsIBA 07/2015 - 01/2001
10	AutoantigensIBA 01/2019 - 06/2000
8	Pharmaceutical PreparationsIBA 03/2022 - 11/2000
8	EpitopesIBA 01/2017 - 11/2000
8	Messenger RNA (mRNA)IBA 01/2008 - 09/2000
7	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2014 - 01/2000
6	KalininIBA 01/2019 - 01/2000
6	Collagen Type VIIIBA 12/2017 - 11/2000
6	Prednisolone (Predate)FDA LinkGeneric 06/2013 - 10/2000
5	Recombinant ProteinsIBA 07/2015 - 01/2001
5	DNA (Deoxyribonucleic Acid)IBA 02/2008 - 01/2000
4	Laminin (Merosin)IBA 01/2021 - 01/2011
4	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 12/2009
4	CollagenIBA 01/2018 - 11/2015
4	Immunoglobulin E (IgE)IBA 07/2017 - 11/2001
4	Desmoglein 3IBA 07/2016 - 11/2000
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2008 - 08/2000
4	Fatty Acids (Saturated Fatty Acids)IBA 02/2006 - 02/2000
3	Cadherins (E-Cadherin)IBA 07/2015 - 03/2000
3	Cholinergic Agents (Cholinergics)IBA 04/2014 - 04/2000
3	Dapsone FDA Link 05/2007 - 11/2001
3	Lansoprazole (Prevacid)FDA LinkGeneric 07/2005 - 07/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2004 - 08/2001
3	Immunoglobulins (Immunoglobulin)IBA 01/2004 - 07/2000
3	Peptides (Polypeptides)IBA 05/2003 - 11/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2001 - 08/2000
3	Glucose (Dextrose)FDA LinkGeneric 09/2001 - 08/2000
3	AcidsIBA 09/2001 - 04/2000
3	PPAR alphaIBA 01/2001 - 09/2000
2	SaltsIBA 04/2019 - 01/2011
2	Collagen Type IV (Type IV Collagen)IBA 01/2017 - 03/2013
2	ParaffinIBA 10/2016 - 07/2001
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 04/2000
2	IntegrinsIBA 02/2015 - 12/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 10/2014 - 06/2013
2	envoplakinIBA 09/2014 - 04/2001
2	Rituximab (Mabthera)FDA Link 06/2014 - 01/2013
2	GABA-A Receptors (GABA(A) Receptor)IBA 04/2014 - 02/2008
2	5- (3- methoxyphenyl)- 3- (5- methyl- 1,2,4- oxadiazol- 3- yl)- 2- oxo- 1,2- dihydro- 1,6- naphthyridineIBA 04/2014 - 01/2014

Therapy/Procedure

24	Therapeutics 01/2022 - 02/2000
7	Drug Therapy (Chemotherapy) 08/2018 - 10/2000
4	Aftercare (After-Treatment) 07/2009 - 11/2000
4	Pallidotomy 11/2003 - 02/2001
4	Liver Transplantation 09/2001 - 11/2000
3	Thoracotomy 01/2013 - 12/2004
2	Injections 02/2016 - 10/2000
2	Home Nursing (Nursing, Home) 09/2015 - 07/2011